| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CTNM returned +72.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +50.4% |
| 1 year | +72.9% |
| All-time high | $20.06 (Jul 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CTNM would be worth today ›No. Contineum Therapeutics, Inc. has not paid a dividend in the past 12 months.
Contineum Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol CTNM.
Contineum Therapeutics, Inc. is part of the Healthcare sector.
Contineum Therapeutics, Inc. has a market cap of 646.71M USD, based on the latest quote.
Contineum Therapeutics, Inc. is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.